back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-08-21 Tx date 2018-07-19 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-193,863.60
-49,455 vol $3.92 each |
0 | |
| Filed 2018-08-21 Tx date 2018-07-16 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-67,980
-16,500 vol $4.12 each |
49,455 | |
| Filed 2018-08-21 Tx date 2018-02-13 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-89,377.20
-21,960 vol $4.07 each |
65,955 | |
| Filed 2017-08-30 Tx date 2017-06-27 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Warrants NeuroBio Exchanged Warrants
55 - Expiration of warrants
|
$-74,992
-3,488 vol $21.50 each |
0 | |
| Filed 2017-08-30 Tx date 2017-06-27 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Call-options
52 - Expiration of options
|
$-225,000
-7,500 vol $30.00 each |
8,250 | |
| Filed 2016-08-22 Tx date 2016-07-13 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-60,000
-5,000 vol $12.00 each |
0 | |
| Filed 2016-08-22 Tx date 2016-07-13 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-6,250
-2,500 vol $2.50 each |
5,000 | |
| Filed 2016-07-18 Tx date 2016-07-14 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$93,000
+75,000 vol $1.24 each |
||
| Filed 2016-07-18 Tx date 2016-07-14 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,000
+75,000 vol $1.24 each |
75,000 | |
| Filed 2016-06-21 Tx date 2016-05-25 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-5,622.25
-523 vol $10.75 each |
0 | |
| Filed 2016-06-21 Tx date 2016-06-16 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-105,000
-7,500 vol $14.00 each |
7,500 | |
| Filed 2016-06-21 Tx date 2016-04-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Warrants NeuroBio Exchanged Warrants
55 - Expiration of warrants
|
$-18,731.44
-1,162 vol $16.12 each |
14,184 | |
| Filed 2016-06-21 Tx date 2016-04-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Warrants NeuroBio Exchanged Warrants
55 - Expiration of warrants
|
$-45,992.80
-5,348 vol $8.60 each |
8,836 | |
| Filed 2016-06-21 Tx date 2016-04-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Warrants NeuroBio Exchanged Warrants
55 - Expiration of warrants
|
$-15,241.80
-1,337 vol $11.40 each |
7,499 | |
| Filed 2016-06-21 Tx date 2016-04-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Warrants NeuroBio Exchanged Warrants
55 - Expiration of warrants
|
$-56,996.31
-4,011 vol $14.21 each |
3,488 | |
| Filed 2015-12-03 Tx date 2015-12-02 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-58,000
-20,000 vol $2.90 each |
523 | |
| Filed 2015-12-03 Tx date 2015-12-02 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Warrants NeuroBio Exchanged Warrants
55 - Expiration of warrants
|
$-56,244
-3,488 vol $16.13 each |
15,346 | |
| Filed 2015-12-03 Tx date 2015-04-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Warrants NeuroBio Exchanged Warrants
55 - Expiration of warrants
|
$-7,060.56
-438 vol $16.12 each |
18,834 | |
| Filed 2015-11-09 Tx date 2014-07-02 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-62,500
-25,000 vol $2.50 each |
45,000 | |
| Filed 2015-11-09 Tx date 2015-04-11 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-78,750
-25,000 vol $3.15 each |
20,523 | |
| Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-135,000 vol |
15,000 | |
| Filed 2015-11-03 Tx date 2015-10-15 |
$NTB
Neptune Technologies & Bioressources Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Call-options
37 - Stock split or consolidation
|
-141,750 vol |
15,750 | |
| Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-65,250 vol |
7,250 | |
| Filed 2015-09-30 Tx date 2014-01-24 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
57 - Exercise of rights
|
$4,766
+3,333 vol $1.43 each |
||
| Filed 2015-09-30 Tx date 2014-01-24 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
57 - Exercise of rights
|
$9,533
+6,667 vol $1.43 each |
59,167 | |
| Filed 2015-09-30 Tx date 2014-01-24 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
-3,333 vol |
||
| Filed 2015-09-30 Tx date 2014-01-24 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-4,766.19
-3,333 vol $1.43 each |
||
| Filed 2015-09-30 Tx date 2014-01-24 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
30 - Acquisition or disposition under a purchase/ownership plan
|
+3,333 vol |
||
| Filed 2015-09-30 Tx date 2014-01-24 |
$APO
Acasti Pharma Inc. |
Denis, Ronald
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-9,533.81
-6,667 vol $1.43 each |
13,333 |